BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 15733014)

  • 1. Candesartan cilexetil: a review of its use in the management of chronic heart failure.
    Fenton C; Scott LJ
    Drugs; 2005; 65(4):537-58. PubMed ID: 15733014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Candesartan cilexetil: a pharmacoeconomic review of its use in chronic heart failure and hypertension.
    Plosker GL; Keam SJ
    Pharmacoeconomics; 2006; 24(12):1249-72. PubMed ID: 17129078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Candesartan in heart failure--assessment of reduction in mortality and morbidity (CHARM): rationale and design. Charm-Programme Investigators.
    Swedberg K; Pfeffer M; Granger C; Held P; McMurray J; Ohlin G; Olofsson B; Ostergren J; Yusuf S
    J Card Fail; 1999 Sep; 5(3):276-82. PubMed ID: 10496201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mortality and morbidity reduction with Candesartan in patients with chronic heart failure and left ventricular systolic dysfunction: results of the CHARM low-left ventricular ejection fraction trials.
    Young JB; Dunlap ME; Pfeffer MA; Probstfield JL; Cohen-Solal A; Dietz R; Granger CB; Hradec J; Kuch J; McKelvie RS; McMurray JJ; Michelson EL; Olofsson B; Ostergren J; Held P; Solomon SD; Yusuf S; Swedberg K;
    Circulation; 2004 Oct; 110(17):2618-26. PubMed ID: 15492298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Candesartan cilexetil--a review of effects on cardiovascular complications in hypertension and chronic heart failure.
    Meredith PA
    Curr Med Res Opin; 2007 Jul; 23(7):1693-705. PubMed ID: 17588300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring new treatment strategies in heart failure.
    Swedberg K
    Blood Press Suppl; 2000; 1():44-8. PubMed ID: 11059637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement in exercise tolerance and symptoms of congestive heart failure during treatment with candesartan cilexetil. Symptom, Tolerability, Response to Exercise Trial of Candesartan Cilexetil in Heart Failure (STRETCH) Investigators.
    Riegger GA; Bouzo H; Petr P; Münz J; Spacek R; Pethig H; von Behren V; George M; Arens H
    Circulation; 1999 Nov; 100(22):2224-30. PubMed ID: 10577995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Candesartan cilexetil: an update.
    Joost A; Schunkert H; Radke PW
    Expert Opin Pharmacother; 2011 Aug; 12(11):1769-80. PubMed ID: 21651457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin receptor blockade with candesartan in heart failure: findings from the Candesartan in Heart failure--assessment of reduction in mortality and morbidity (CHARM) programme.
    Ostergren JB
    J Hypertens Suppl; 2006 Mar; 24(1):S3-7. PubMed ID: 16601570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute and 3-month treatment effects of candesartan cilexetil on hemodynamics, neurohormones, and clinical symptoms in patients with congestive heart failure.
    Mitrovic V; Willenbrock R; Miric M; Seferovic P; Spinar J; Dabrowski M; Kiowski W; Marks DS; Alegria E; Dukát A; Lenz K; Arens HA
    Am Heart J; 2003 Mar; 145(3):E14. PubMed ID: 12660683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Candesartan cilexetil in the treatment of chronic heart failure.
    Baguet JP; Barone-Rochette G; Neuder Y
    Vasc Health Risk Manag; 2009; 5(1):257-64. PubMed ID: 19436650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined angiotensin receptor blocker and ACE inhibitor on myocardial fibrosis and left ventricular stiffness in dogs with heart failure.
    Funabiki K; Onishi K; Dohi K; Koji T; Imanaka-Yoshida K; Ito M; Wada H; Isaka N; Nobori T; Nakano T
    Am J Physiol Heart Circ Physiol; 2004 Dec; 287(6):H2487-92. PubMed ID: 15548724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined blockade of AT1-receptors and ACE synergistically potentiates antihypertensive effects in SHR.
    Raasch W; Jöhren O; Schwartz S; Gieselberg A; Dominiak P
    J Hypertens; 2004 Mar; 22(3):611-8. PubMed ID: 15076168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential clinical profile of candesartan compared to other angiotensin receptor blockers.
    Cernes R; Mashavi M; Zimlichman R
    Vasc Health Risk Manag; 2011; 7():749-59. PubMed ID: 22241949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Candesartan: widening indications for this angiotensin II receptor blocker?
    Mendis B; Page SR
    Expert Opin Pharmacother; 2009 Aug; 10(12):1995-2007. PubMed ID: 19563275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The safety and tolerability of candesartan cilexetil in CHF.
    Erdmann E; George M; Voet B; Belcher G; Kolb D; Hiemstra S; Pietrek M; Held P
    J Renin Angiotensin Aldosterone Syst; 2000 Sep; 1 Suppl 1():31-6. PubMed ID: 11967795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program.
    Ducharme A; Swedberg K; Pfeffer MA; Cohen-Solal A; Granger CB; Maggioni AP; Michelson EL; McMurray JJ; Olsson L; Rouleau JL; Young JB; Olofsson B; Puu M; Yusuf S;
    Am Heart J; 2006 Jul; 152(1):86-92. PubMed ID: 16838426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: assessment of Reduction in Mortality and morbidity (CHARM) program.
    Ducharme A; Swedberg K; Pfeffer MA; Cohen-Solal A; Granger CB; Maggioni AP; Michelson EL; McMurray JJ; Olsson L; Rouleau JL; Young JB; Yusuf S
    Am Heart J; 2006 May; 151(5):985-91. PubMed ID: 16644318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of oral candesartan cilexetil in patients with congestive heart failure.
    Matsumori A;
    Eur J Heart Fail; 2003 Oct; 5(5):669-77. PubMed ID: 14607207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized trial of candesartan cilexetil in the treatment of patients with congestive heart failure and a history of intolerance to angiotensin-converting enzyme inhibitors.
    Granger CB; Ertl G; Kuch J; Maggioni AP; McMurray J; Rouleau JL; Stevenson LW; Swedberg K; Young J; Yusuf S; Califf RM; Bart BA; Held P; Michelson EL; Sellers MA; Ohlin G; Sparapani R; Pfeffer MA
    Am Heart J; 2000 Apr; 139(4):609-17. PubMed ID: 10740141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.